Author: Finnegan Delacroix - Page 4

Anticholinergic medications like Benadryl and oxybutynin may increase dementia risk with long-term use. Learn which drugs are most dangerous, how to spot the signs, and safer alternatives to protect your brain.

Many medications cause heartburn and upset stomach, but you don’t have to suffer. Learn which pills are most likely to trigger symptoms and how to manage them safely without stopping your treatment.

Learn which statins are safe to take with HIV medications, which ones to avoid, and how to prevent dangerous muscle damage. Essential guidance for people on antiretroviral therapy needing cholesterol control.

Medicare Part D now caps out-of-pocket drug costs at $2,000 in 2025, saving beneficiaries hundreds on generic medications. Learn how copays, formularies, and plan types affect your savings.

Many people think they're allergic to penicillin, but most aren't. Learn how to tell the difference between a true allergy and a side effect, how to get tested, and what safe alternatives exist-without risking your health or wasting money.

Grapefruit juice can dangerously increase drug levels in your blood by blocking enzymes that break down medications. Learn which pills are risky, why even small amounts matter, and what safe alternatives exist.

Caffeine can interfere with medications like warfarin, thyroid pills, and antidepressants, leading to dangerous side effects or reduced effectiveness. Learn which drugs are affected and how to stay safe.

Learn how the FDA and state pharmacy boards work together to regulate online pharmacies, spot unsafe sites, and protect yourself from counterfeit drugs in 2025.

Pharmacists navigate complex insurance rules requiring patients to try generic drugs before brand-name ones. Learn how prior authorization works, why it delays care, and what strategies actually work to get approvals faster.

IVIVC lets pharmaceutical companies replace costly human bioequivalence trials with lab-based dissolution tests. Learn how this science works, why most submissions fail, and when it’s the right choice for generic drug approval.